Imad Sheiban

Summary

Publications

  1. ncbi request reprint Sex-related differences in patients undergoing percutaneous unprotected left main stenting
    Imad Sheiban
    Divisione di Cardiologia, Universita di Torino, Turin, Italy
    EuroIntervention 5:795-800. 2010
  2. ncbi request reprint [Left main coronary artery stenosis]
    Imad Sheiban
    Divisione di Cardiologia, Universita degli Studi, Ospedale San Giovanni Battista Molinette, Torino
    G Ital Cardiol (Rome) 9:684-9. 2008
  3. ncbi request reprint Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am J Cardiol 100:431-5. 2007
  4. ncbi request reprint Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:582-8. 2007
  5. doi request reprint Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:783-8. 2008
  6. ncbi request reprint The retrograde coronary approach for chronic total occlusions: mid-term results and technical tips & tricks
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Interv Cardiol 20:466-73. 2007
  7. doi request reprint Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:213-6. 2008
  8. doi request reprint Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn?
    Imad Sheiban
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
    Catheter Cardiovasc Interv 74:805-7. 2009
  9. doi request reprint Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Clin Res Cardiol 97:891-8. 2008
  10. doi request reprint Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry
    Imad Sheiban
    Laboratory of Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 10:461-8. 2009

Detail Information

Publications100

  1. ncbi request reprint Sex-related differences in patients undergoing percutaneous unprotected left main stenting
    Imad Sheiban
    Divisione di Cardiologia, Universita di Torino, Turin, Italy
    EuroIntervention 5:795-800. 2010
    ..Limited data are available on sex-related differences in this setting. We investigated gender-associated differences in patients undergoing stent-based PCI for ULM...
  2. ncbi request reprint [Left main coronary artery stenosis]
    Imad Sheiban
    Divisione di Cardiologia, Universita degli Studi, Ospedale San Giovanni Battista Molinette, Torino
    G Ital Cardiol (Rome) 9:684-9. 2008
    ....
  3. ncbi request reprint Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am J Cardiol 100:431-5. 2007
    ..No case of stent thrombosis was reported. In conclusion, this single-center experience suggests that percutaneous use of SESs to treat LM disease in unselected high-risk patients is safe and effective even 1 year after implantation...
  4. ncbi request reprint Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:582-8. 2007
    ..The aim of this study was to evaluate the safety and efficacy of PESs in a 'real-world' population...
  5. doi request reprint Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:783-8. 2008
    ..We aimed to appraise whether the effectiveness of drug-eluting stents for in-stent restenosis is maintained even in the long term...
  6. ncbi request reprint The retrograde coronary approach for chronic total occlusions: mid-term results and technical tips & tricks
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Interv Cardiol 20:466-73. 2007
    ..The retrograde approach is a novel but still incompletely described technique. We report our 5-year-long experience in retrograde percutaneous coronary intervention (PCI) for CTOs...
  7. doi request reprint Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:213-6. 2008
  8. doi request reprint Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn?
    Imad Sheiban
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
    Catheter Cardiovasc Interv 74:805-7. 2009
    ..We report hereby a case in which we employed a buddy wire and balloon technique as a "shoehorn" to enable accurate delivery of a balloon-expandable aortic valve prosthesis from the transfemoral route...
  9. doi request reprint Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Clin Res Cardiol 97:891-8. 2008
    ..The aim of the present study was to test in a porcine model the safety and efficacy of a novel Genistein-eluting balloon preceding coronary stenting...
  10. doi request reprint Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry
    Imad Sheiban
    Laboratory of Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 10:461-8. 2009
    ..Although multivessel disease and stenting are frequent in this population, pertinent details on short-term and long-term outcomes are lacking...
  11. doi request reprint Update on dedicated bifurcation stents
    Imad Sheiban
    From the Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Interv Cardiol 22:150-5. 2009
    ..The development of further drug-eluting platforms and larger controlled studies should demonstrate their clinical applicability, efficacy, and safety before they are widely incorporated into daily practice...
  12. doi request reprint A prospective multicentre observational study on the management of unprotected left main coronary artery disease: rationale and design of the Registro Italiano sul Trattamento del tronco comune non protetto study
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:826-30. 2008
    ..We designed a prospective multicentre registry, which will include patients with unprotected left main disease independent of the subsequent medical, interventional or surgical treatment...
  13. doi request reprint Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    Catheter Cardiovasc Interv 73:25-31. 2009
    ..We aimed to conduct a retrospective cohort study focusing on our 5-year experience in the percutaneous treatment of unprotected left main (ULM) trifurcation disease...
  14. doi request reprint Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:1246-53. 2008
    ..Percutaneous coronary intervention with drug-eluting stent implantation is increasingly used for ULM disease. However, there are no data on the clinical results of drug-eluting stents for ULM disease in patients with diabetes...
  15. ncbi request reprint Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow up
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
    J Invasive Cardiol 19:174-80. 2007
    ..Studies focusing on short- and mid-term follow up support the beneficial role of sirolimus-eluting stents (SES) in the treatment of in-stent restenosis (ISR), yet no long-term safety and/or efficacy data are available...
  16. ncbi request reprint Evolving standard in the treatment of coronary artery disease. Drug-eluting stents
    I Sheiban
    Interventional Cardiology Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Minerva Cardioangiol 51:485-92. 2003
    ..This paper will discuss the main results of the clinical trial programs of the DES (mentioned above) available for clinical use in the present time and analyze technical and procedural aspects which could affect long term outcome...
  17. ncbi request reprint Drug-eluting stent: the emerging technique for the prevention of restenosis
    I Sheiban
    Interventional Cardiology, Division of Cardiology, San Giovanni Battista Hospital, University of Turin, Turin, Italy
    Minerva Cardioangiol 50:443-53. 2002
    ..Based on the very impressive results available at the present time, we can expect, in the very near future, remarkable changes in our clinical practice and the beginning of a new "era" of interventional cardiology...
  18. ncbi request reprint Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerations
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Ital Heart J 5:638-41. 2004
    ..The purpose of this case report was to review the incidence and angiographic evaluation of an anomalous coronary vessel and to discuss the technical approach to an anomalous left main intervention and its impact on clinical outcome...
  19. ncbi request reprint Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction
    I Sheiban
    Department of Internal Medicine, University of Torino, Ospedale San Giovanni Battista Molinette, Italy
    J Am Coll Cardiol 38:464-71. 2001
    ....
  20. ncbi request reprint Influence of treatment delay on long-term left ventricular function in patients with acute myocardial infarction successfully treated with primary angioplasty
    I Sheiban
    Divisione di Cardiologia Universitaria, Dipartimento di Medicina Interna, Universita di Torino, Ospedale San Giovanni Batista, Corso Bramante 88 90 10126 Torino, Italy
    Am Heart J 141:603-9. 2001
    ..The aim of this study was to evaluate the importance of time to reperfusion for left ventricular function recovery after primary angioplasty (percutaneous transluminal coronary angioplasty [PTCA]) for AMI...
  21. ncbi request reprint Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease
    I Sheiban
    Department of Internal Medicine, University of Turin, Italy
    Ital Heart J 1:480-6. 2000
    ..The clinical outcome and the predictors of the outcome of patients receiving multiple stents are not known...
  22. ncbi request reprint Iatrogenic left internal mammary artery-coronary vein anastomosis treated with covered stent deployment via retrograde percutaneous coronary sinus approach
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Catheter Cardiovasc Interv 68:704-7. 2006
    ..Percutaneous treatment of acquired coronary fistula with covered stent..
  23. ncbi request reprint Immediate and medium-term outcomes following the treatment of very long (> or =50 mm) chronic total coronary artery occlusions
    Imad Sheiban
    Division of Cardiology, Interventional Cardiology Laboratory, University of Torino, Torino, Italy
    J Invasive Cardiol 16:5-9. 2004
    ..The aim of the present study was to evaluate the early results and mid-term outcomes following angioplasty of such lesions...
  24. doi request reprint Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function
    Mario Bollati
    Division of Cardiology, University of Turin, Turin, Italy
    Catheter Cardiovasc Interv 75:586-93. 2010
    ..We aimed to appraise the early and long-term outcome after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients with unprotected left main disease (ULM) and left ventricular systolic dysfunction (LVD)...
  25. doi request reprint Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients
    Giuseppe Biondi-Zoccai
    Divisione di Cardiologia, Universita di Torino, San Giovanni Battista Molinette Hospital, Corso Bramante 88 90, 10126, Turin, Italy
    Clin Res Cardiol 100:403-11. 2011
    ..We thus appraised the prognostic role of left ventricular ejection fraction (LVEF) in patients undergoing PCI for ULM with drug-eluting stents (DES)...
  26. doi request reprint Gender differences in patients undergoing TAVI: a multicentre study
    Fabrizio D'Ascenzo
    Division of Cardiology, San Giovanni Battista Molinette, University of Turin, Turin, Italy
    EuroIntervention 9:367-72. 2013
    ....
  27. ncbi request reprint Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention
    Giorgio Quadri
    Division of Cardiology, Azienda Ospedaliera CittB della Salute e della Scienza, Turin, Italy
    Acta Cardiol 68:151-60. 2013
    ....
  28. doi request reprint Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease
    Marco Novara
    Department of Cardiology, S Giovanni Battista Molinette Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 13:368-75. 2012
    ..To investigate the relationship between classic SYNTAX and functional SYNTAX score guided by fractional flow reserve (FFR)...
  29. ncbi request reprint A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions
    Francesco Colombo
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
    Acta Cardiol 64:583-8. 2009
    ..We thus aimed to appraise the long-term (> 2 years) outcomes of patients with bifurcation lesions treated with DES vs. BMS...
  30. doi request reprint Appraising the pathophysiologic impact of coronary collaterals as measured by fractional flow reserve on symptoms and signs of myocardial ischemia
    Claudio Moretti
    Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:1120-6. 2008
    ..A major factor in this complex lesion-myocardium interaction is collateral flow. We aimed to define which collateral flow cut-offs separate asymptomatic from symptomatic patients during coronary occlusion...
  31. doi request reprint The future of new aortic valve replacement approaches
    Mario Bollati
    Division of Cardiology, University of Torino, Corso Bramante 88 90, 10126 Torino, Italy
    Future Cardiol 6:351-60. 2010
    ....
  32. doi request reprint Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry
    Giuseppe Biondi-Zoccai
    Division of Cardiology, University of Modena and Reggio Emilia, Modena, Italy
    Clin Res Cardiol 100:1021-8. 2011
    ..We aimed to compare IVUS-guided PCI versus standard PCI in a large registry of patients undergoing PCI for bifurcations in the drug-eluting stent era...
  33. doi request reprint Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
    Catheter Cardiovasc Interv 74:313-20. 2009
    ..We compared our long-term results of a simple vs complex stenting strategy in patients with bifurcation lesions...
  34. ncbi request reprint Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am Heart J 153:587-93. 2007
    ..We performed a systematic review and meta-regression of randomized clinical trials comparing clopidogrel versus ticlopidine, focusing on clopidogrel front-loading...
  35. doi request reprint Percutaneous coronary intervention for small vessel coronary artery disease
    Giuseppe Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, 10126 Turin, Italy
    Cardiovasc Revasc Med 11:189-98. 2010
    ..The present article provides a concise and updated review on percutaneous coronary revascularization in patients with symptomatic small vessel coronary artery disease...
  36. doi request reprint Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, Turin, Italy
    J Interv Cardiol 25:611-21. 2012
    ..We aimed to appraise the performance of current multivariable approaches in the estimation of causal treatment and effects in studies focusing on drug-eluting stents (DES)...
  37. doi request reprint Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry
    Giuseppe G L Biondi-Zoccai
    S Giovanni Battista Molinette Hospital, University of Turin, Italy
    Clin Res Cardiol 99:235-42. 2010
    ..We aimed to retrospectively compare the outcome of patients with ULM treated with DES according to their follow-up management strategy...
  38. doi request reprint Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
    Giuseppe G L Biondi-Zoccai
    Division of Cardiology, University of Turin, Turin, Italy
    Am Heart J 155:1081-9. 2008
    ..We systematically reviewed randomized clinical trials (RCTs) on the angiographic and clinical impact of cilostazol after PCI...
  39. pmc Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Corso Bramante 88 90, Turin 10126, Italy
    Eur Heart J 33:875-80. 2012
    ..We thus performed a comprehensive review of studies focusing on ACS in HIV patients...
  40. doi request reprint 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study
    Fabrizio D'Ascenzo
    Division of Cardiology, San Giovanni Battista Molinette, University of Turin, Turin, Italy
    Int J Cardiol 167:1514-8. 2013
    ..In patients undergoing TAVI no study was performed to evaluate outcomes according to renal clearance, which represents the most accurate instrument to assess kidney function...
  41. doi request reprint Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease
    Emanuele Meliga
    Interventional Cardiology Unit, A O Ordine Mauriziano Umberto I, Turin, Italy
    J Interv Cardiol 24:535-41. 2011
    ..Optimal management of multivessel disease (MVD) in ST-segment elevation myocardial infarction (STEMI) patients treated by primary percutaneous coronary intervention (PCI) is still unclear...
  42. pmc Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Vasc Health Risk Manag 4:31-8. 2008
    ..Only indirect meta-analyses can be used to date to compare the Xience V with the Cypher. This systematic review tries to provide a concise and critical appraisal of the data in support of the Xience V everolimus-eluting stent...
  43. ncbi request reprint Intra-arterial lidocaine versus saline to reduce peri-procedural discomfort in patients undergoing percutaneous trans-radial or trans-ulnar coronary procedures
    Giuseppe G L Biondi-Zoccai
    Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
    Acta Cardiol 66:9-14. 2011
    ..We aimed to compare intraarterial lidocaine versus saline to reduce peri-procedural discomfort during percutaneous trans-radial or trans-ulnar procedures...
  44. doi request reprint Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, Turin, Italy
    Am J Cardiol 107:651-4. 2011
    ..Also, despite their greater baseline risk profile, women were significantly less likely to have received effective treatment, the use of including drug-eluting stents...
  45. doi request reprint Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes
    Giuseppe Biondi-Zoccai
    Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
    Int J Cardiol 150:325-31. 2011
    ..However, there is no comparison of prasugrel vs. ticagrelor. We performed an adjusted indirect meta-analysis comparing prasugrel vs. ticagrelor for acute coronary syndromes (ACSs)...
  46. doi request reprint Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty
    Giuseppe Biondi-Zoccai
    Division of Cardiology, University of Turin, Turin, Italy
    Am Heart J 160:S28-35. 2010
    ....
  47. doi request reprint Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?
    Mario Bollati
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:403-5. 2008
    ..This clinical vignette suggests that suboptimal drug-eluting stent deployment may be associated with stent thrombosis well after the traditional time frame of subacute thrombosis...
  48. doi request reprint Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies
    Davide G Presutti
    aDivision of Cardiology, Department of Internal Medicine, Turin, Italy bDepartment of Cardiology, St Joseph s Regional Medical Center, Paterson, New Jersey cDivision of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California, USA dDivision of Interventional Cardiology, Instituto Cardiovascular, Hospital La Paz, Paseo La Castellana, Madrid, Spain eDepartment of Medico Surgical Sciences, Biotechnologies Sapienza University of Rome, Italy fInvasive Cardiology, Campus Middelheim, Antwerpen, Belgium gMeta analysis and Evidence based medicine Training in Cardiology, Italy
    J Cardiovasc Med (Hagerstown) 14:773-9. 2013
    ..We, thus, aimed to perform a systematic review and meta-analysis of clinical studies reporting on PCI with stenting in nonagenarians...
  49. doi request reprint TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, Turin, Italy
    Contemp Clin Trials 33:507-14. 2012
    ..Acute coronary syndromes (ACS) represent a difficult challenge for physicians. Risk scores have become the cornerstone in clinical and interventional decision making...
  50. doi request reprint Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Corso Bramante 88 90, Turin 10126, Italy
    Heart 98:914-9. 2012
    ..Thus the aim of this study was to perform an international collaborative systematic review and meta-analysis to appraise the prevalence and predictors of LMD and 3VD...
  51. doi request reprint Quantitative coronary angiography in the current era: principles and applications
    Paolo Garrone
    Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
    J Interv Cardiol 22:527-36. 2009
    ..This review aims thus to provide a comprehensive and updated viewpoint on the actual role of QCA...
  52. doi request reprint A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am Heart J 155:274-83. 2008
    ..Drug-eluting stent (DES) implantation has been recently reported in patients with ULM but with unclear results. We systematically reviewed outcomes of percutaneous DES implantation in ULM...
  53. doi request reprint Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, Turin, Italy
    Int J Cardiol 167:575-84. 2013
    ..However, data on its incidence and predictors are sparse and conflicting. We thus aimed to perform a collaborative systematic review on incidence and predictors of stent thrombosis...
  54. doi request reprint Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement
    Fabrizio D'Ascenzo
    aDivision of Cardiology, Department of Internal Medicine, Città Della Salute e Della Scienza bDivision of Cardiac Surgery, San Giovanni Battista Molinette, University of Turin, Turin cDivision of Cardiology, Azienda Ferrarotto Hospital, University of Catania, Catania dDepartment of Medico Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome eDivision of Cardiology, Istituto Clinico Humanitas, Milan fDivision of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy
    J Cardiovasc Med (Hagerstown) 14:894-8. 2013
    ..We compared available surgical risk scores to describe unfavorable outcomes after TAVI...
  55. doi request reprint Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study)
    Imad Sheiban
    University of Turin, Italy
    J Am Coll Cardiol 54:1131-6. 2009
    ..This study sought to retrospectively appraise the incidence and management of restenosis after drug-eluting stent (DES) implantation for unprotected left main (ULM) disease...
  56. doi request reprint Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients
    Giuseppe G L Biondi-Zoccai
    Division of Cardiology, University of Turin, Italy
    J Endovasc Ther 16:251-60. 2009
    ..To report a systematic review of the literature published on the outcomes of stenting for below-the-knee disease in patients with critical limb ischemia (CLI)...
  57. doi request reprint Percutaneous coronary intervention on left main coronary artery trifurcation
    Matteo Anselmino
    Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
    Heart Vessels 23:279-81. 2008
    ..We therefore describe a case of successful PCI on a left main trifurcation supported by pre-and post-intravascular ultrasound iconography...
  58. ncbi request reprint Safety of drug-coated stents
    Giuseppe Gl Biondi-Zoccai
    University of Turin, S Giovanni Battista Molinette Hospital, Interventional Cardiology, Division of Cardiology, Corso Bramante 88 90, 10126 Turin, Italy
    Expert Opin Drug Saf 7:597-606. 2008
    ..However, a number of safety concerns have been raised on DES...
  59. doi request reprint Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis
    Fabrizio D'Ascenzo
    Division of Cardiology, University of Turin, Turin, Italy
    Heart 98:1267-71. 2012
    ....
  60. ncbi request reprint Myocardial viability after primary coronary angioplasty: low-dose dobutamine stress echocardiography versus myocardial contrast echocardiography
    Mara Morello
    Division of Cardiology, Department of Internal Medicine, University of Turin, Turin, Italy
    Ital Heart J 5:530-5. 2004
    ..The aim of our study was to compare LDDSE and MCE, in the prediction of the recovery of segments in patients with AMI who were submitted to primary coronary angioplasty (PTCA)...
  61. doi request reprint A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:957-62. 2008
    ....
  62. ncbi request reprint Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis
    Giuseppe Biondi Zoccai
    Division of Cardiology, University of Turin, Turin, Italy
    EuroIntervention 3:409-15. 2007
    ..While event attrition remains substantial at long-term follow-up, drug-eluting stents hold the promise of significantly improving event-free and overall survival...
  63. ncbi request reprint Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular dysfunction
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Torino, San Giovanni Battista Hospital, Torino, Italy
    EuroIntervention 3:359-64. 2007
    ..Conclusions: In symptomatic patients with CAD and severe left ventricular dysfunction, PCI can be performed with excellent procedural outcome and acceptable long-term morbidity and mortality...
  64. doi request reprint Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY
    Dario Sillano
    Division of Interventional Cardiology, University of Turin, Turin, Italy
    Catheter Cardiovasc Interv 82:414-21. 2013
    ..The aim of this observational, multicenter study was to describe the outcome of very elderly patients undergoing percutaneous coronary intervention (PCI)...
  65. ncbi request reprint Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    EuroIntervention 3:381-5. 2007
    ....
  66. ncbi request reprint In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment
    Angela Pucci
    Pathology Department, Regina Margherita Hospital, Turin, Italy
    Atherosclerosis 194:189-95. 2007
    ..Aim of the study was to investigate whether maintained moderate statin treatment influence atheroma, macrophage content, neoangiogenesis and/or haemorrhage in coronary plaques from patients with non-fatal coronary syndromes...
  67. pmc Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure
    Claudio Moretti
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Heart Int 6:e3. 2011
    ..Knowledge of this potential complication is important to minimize its occurance and provide appropriate treatment...
  68. ncbi request reprint Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis
    D Sillano
    Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
    Minerva Cardioangiol 56:167-70. 2008
    ..This case highlights the potentials and drawbacks of percutaneous coronary intervention for unprotected left main disease, suggesting nonetheless, that this revascularization strategy can be safely repeated even in elderly patients...
  69. doi request reprint Impact of TAVI on mitral regurgitation: a prospective echocardiographic study
    Francesca Giordana
    Medical Sciences Department, San Giovanni Battista Molinette Hospital, University of Torino, Italy
    Echocardiography 30:250-7. 2013
    ..Conclusions: This multiparametric echocardiographic evaluation showed that MR improved significantly after TAVI and that this result may be related to the type of valve implanted...
  70. ncbi request reprint A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Corso Bramante 88 90, 10126 Turin, Italy
    Eur Heart J 27:2667-74. 2006
    ..We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD...
  71. doi request reprint Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)
    E Meliga
    Department of Interventional Cardiology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands Department of Interventional Cardiology, S Giovanni Battista Hospital, Turin, Italy
    Int J Cardiol 137:16-21. 2009
    ....
  72. ncbi request reprint Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher)
    G Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Minerva Cardioangiol 56:55-65. 2008
    ..Whether long-term results and direct comparison to Cypher will also be favorable remains to be established by future clinical trials...
  73. doi request reprint Homing of annexin-labeled stem cells to apoptotic cells
    Argyrios Gerasimou
    Interventional Cardiology, Division of Cardiology, University of Torino, Torino, Italy
    Cell Mol Biol Lett 14:100-12. 2009
    ..Therefore, stem cell ANXA5 tagging via biotin-avidin bridges could be a straightforward method of improving homing to apoptotic tissues...
  74. ncbi request reprint Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
    G Fragasso
    Divisione di Cardiologia, Istituto Scientifico H San Raffaele, Milan, Italy
    J Am Coll Cardiol 34:441-7. 1999
    ....
  75. ncbi request reprint Safety of coronary collateral stenting in a patient with acute coronary syndrome
    M Anselmino
    Interventional Cardiology, Division of Cardiology University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Minerva Cardioangiol 56:693-6. 2008
    ..In the present case balloon angioplasty and stenting of the collateral vessel was safe and effective. Nonetheless, further studies are warranted...
  76. ncbi request reprint Iatrogenic coronary-to-right ventricle fistula: benign outcome irrespective of patency?
    M Anselmino
    Cardiology Unit, Department of Medicine, University of Turin, Turin, Italy
    Minerva Cardioangiol 56:365-9. 2008
    ....
  77. ncbi request reprint Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients
    M Anselmino
    Cardiology Unit, San Giovanni Battista, Molinette Hospital, University of Turin, Turin, Italy
    Minerva Cardioangiol 57:151-7. 2009
    ....
  78. ncbi request reprint Images in cardiology: Percutaneous coronary angioplasty of a single coronary artery originating above the left sinus of Valsalva
    I Sheiban
    Department of Cardiology, Molinette Hospital, University of Turin, Turin, Italy
    Clin Cardiol 27:412. 2004
  79. ncbi request reprint Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary interventions
    S Delcrè
    Cardiology Unit, San Giovanni Battista Molinette Hospital, University of Turin, Turin, Italy
    Minerva Cardioangiol 56:267-75. 2008
    ....
  80. ncbi request reprint Impact of multivessel coronary disease on long-term outcome after percutaneous recanalization of coronary chronic total occlusions
    C La Spina
    Division of Cardiology, University of Turin, Turin, Italy
    Minerva Cardioangiol 58:159-65. 2010
    ..Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is common even with concomitant multivessel disease. We aimed to investigate the impact of multivessel disease on long-term outcome after PCI for CTO...
  81. doi request reprint C-reactive protein and coronary composition in patients with percutaneous revascularization
    A Pucci
    Regina Margherita Hospital, ASO OIRM S Anna, Turin, Italy
    Eur J Clin Invest 38:281-9. 2008
    ..Whether serum CRP levels are associated with in vivo atherothrombotic features is unclear. We thus analysed samples from coronary atherectomy specimens obtained during percutaneous coronary intervention...
  82. ncbi request reprint Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting
    M Anselmino
    Cardiology Division, Department of Medicine, University of Turin, San Giovanni Battista Hospital, Turin, Italy
    Minerva Cardioangiol 58:277-80. 2010
    ..The description of this exceptional clinical case is of relevant knowledge to orientate a physician treating a patient with absolute need of antiplatelets and history of previous drug-induced reactions...
  83. ncbi request reprint Repeat adverse events long after percutaneous coronary revascularization in diabetics
    E Cavallero
    Division of Cardiology, University of Turin, Turin, Italy
    Minerva Cardioangiol 58:23-34. 2010
    ..However, recurrence rates of after the first revascularization have never been appraised. The aim of this study was to evaluate recurrent events in diabetics undergoing percutaneous coronary intervention (PCI) in the current era...
  84. ncbi request reprint Short and long-term outcomes of percutaneous revascularization in patients with prior coronary artery bypass graft
    F D'Ascenzo
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Minerva Cardioangiol 58:291-9. 2010
    ....
  85. ncbi request reprint Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry
    Alaide Chieffo
    San Raffaele Scientific Institute and EMO Centro Cuore Columbus, Via Olgettina 60, 20132 Milan, Italy
    Circulation 116:158-62. 2007
    ..The presence of a lumen narrowing at the ostium and the body of an unprotected left main coronary artery but does not require bifurcation treatment is a class I indication of surgical revascularization...
  86. ncbi request reprint Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 71:175-83. 2008
    ..They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented...
  87. ncbi request reprint Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEG
    Marco Valgimigli
    Cardiology, University of Ferrara, Ferrara, Italy
    Am Heart J 154:39-45. 2007
    ..Similarly, whether tirofiban administered at high-bolus dose (HBD) followed by standard infusion is a valuable alternative to abciximab in the setting of ST-segment elevation myocardial infarction remains uncertain...
  88. doi request reprint ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients
    Tania Chechi
    Cardiologia e Cardiologia Invasiva 2, A O U Careggi, Florence, Italy
    J Am Coll Cardiol 51:2396-402. 2008
    ..The aim of this retrospective study was to compare clinical and angiographic outcomes between patients presenting with ST-segment elevation myocardial infarction (STEMI) due to stent thrombosis (ST) and de novo coronary thrombosis...
  89. ncbi request reprint Effect of estradiol 17beta upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patients
    Giuseppe M C Rosano
    Department of Medical Sciences, IRCCS San Raffaele Hospital, Tosinvest Sanita, via della Pisana 235, 00164 Roma, Italy
    Int J Cardiol 107:254-9. 2006
    ..The aim of the present study was to evaluate the effect of acute administration of estradiol 17beta upon coronary artery reactivity to methylergometrine in 16 menopausal patients with coronary artery disease...
  90. ncbi request reprint Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent
    Antonio Luca Bartorelli
    Institute of Cardiology, University of Milan, Centro Cardiologico Monzino, IRCCS, Milan, Italy
    Am J Cardiol 99:1062-6. 2007
    ..94 to 5.85, p = NS). In conclusion, after optimal intracoronary implantation of the CarboStent, antiplatelet therapy with aspirin alone was safe and provided efficacy comparable to aspirin plus a thienopyridine in the prevention of ST...
  91. doi request reprint Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry
    Emanuele Meliga
    Department of Interventional Cardiology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
    J Am Coll Cardiol 51:2212-9. 2008
    ..The purpose of this study was to investigate the long-term safety and efficacy of percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation for unprotected left main coronary artery (ULMCA) disease...
  92. doi request reprint Letter by Bollati et al regarding article, "Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization"
    Mario Bollati
    Circulation 117:e187; author reply e188. 2008
  93. doi request reprint Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials
    Antonio Abbate
    Virginia Commonwealth University VCU Pauley Heart Center, Richmond, Virginia 23298, USA
    J Am Coll Cardiol 51:956-64. 2008
    ....
  94. doi request reprint Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease"
    Matteo Anselmino
    Circulation 117:e166; author reply e167. 2008
  95. ncbi request reprint Comment on the 'pilot' GRACIA-2 randomized trial
    Gianluca Villata
    Eur Heart J 28:2417-8; author reply 2418-9. 2007
  96. doi request reprint Revisiting the role of percutaneous revascularization versus medical therapy for later infarct-related artery occlusion (letter of comment on Ioannidis and Katritsis. Am Heart J. 2007;154:1065-71)
    Darryn Appleton
    Am Heart J 155:e41; author reply e43. 2008
  97. ncbi request reprint Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention
    Marzia Lotrionte
    Institute of Cardiology, Catholic University, Rome, Italy
    Am J Cardiol 100:1199-206. 2007
    ..In conclusion, a high clopidogrel loading dose (>300 mg) significantly reduces early ischemic events in patients scheduled for percutaneous coronary intervention...
  98. ncbi request reprint Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials
    Michael J Lipinski
    Department of Internal Medicine, University of Virginia, Charlottesville, Virginia, USA
    J Am Coll Cardiol 50:1761-7. 2007
    ..We aimed to perform a meta-analysis of clinical trials on intracoronary cell therapy after acute myocardial infarction (AMI)...
  99. doi request reprint Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial
    Marco Valgimigli
    Cardiovascular Institute, University of Ferrara, Ferrara, Italy
    JAMA 299:1788-99. 2008
    ..Similarly, the use of drug-eluting stents in this patient population is currently discouraged because of conflicting results on efficacy reported in randomized trials and safety concerns reported by registries...
  100. ncbi request reprint Comparison of different methods of measurement of aspirin resistance: using the appropriate statistic
    Marzia Lotrionte
    Eur Heart J 29:138; author reply 138-9. 2008